Research Blood Components Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Research Blood Components

Access the complete profile.

Research Blood Components Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	621991 Blood & Organ Banks
Address	63 Pleasant St Ste 400 Watertown, MA 02472

Note: Revenues for privately held companies are statistical evaluations.


Research Blood Components's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Research Blood Components's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Research Blood Components is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Research Blood Components Annual Revenue and Growth Rate

Research Blood Components	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Research Blood Components's revenues are gauged from an analysis of company filings.

Research Blood Components's Income Statement (based on Industry Averages)

Research Blood Components P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Research Blood Components's Largest Competitors

A competitive analysis shows these companies are in the same general field as Research Blood Components, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Research Blood Components. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	100
SOBI	Waltham, MA	3
TRIANA BIOMEDICINES	Waltham, MA	0
AVILAR THERAPEUTICS	Waltham, MA	0
RESEARCH BLOOD COMPONENTS	Watertown, MA	0

Future Competition: Research Blood Components's Fastest Growing Competitors

These companies are in the same general field as Research Blood Components and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)